ONXX
ONXX Articles
ThinkstockInvesting in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited pipelines or their very survival depends on a single binary event that...
Published:
Last Updated:
ThinkstockThe dread and fear that can come with a cancer diagnosis have their roots in its killer nature. It is the number two cause of death in Americans, second only to heart disease, according to...
Published:
Last Updated:
Frank Golhen, via Wikimedia CommonsMany stocks are on the move this Wednesday morning and we are covering some of the key winners and losers for our readers. Boeing Co. (NYSE: BA) is trading lower...
Published:
ThinkstockBig biotech had a stellar 2012. In 2013, though, the large biotech companies may be dwarfed in performance by the smaller players in the $1 billion to $5 billion range. If you look at the...
Published:
Last Updated:
Thinkstock24/7 Wall St. is looking for the next great biotech stocks for 2013 after great gains have been seen in 2012. If you look at the consensus price targets from analysts for the coming 12...
Published:
Last Updated:
U.S. equity markets opened flat to higher this morning but the good vibe didn’t last long. In Europe, the Bank of England made no changes either to interest rates or its bond buying program....
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Wednesday. BB&T Corp. (NYSE: BBT) cut to Equal Weight at Morgan Stanley. Central...
Published:
Last Updated:
These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Wednesday. ADTRAN Inc. (NASDAQ: ADTN) cut to Sell at Citigroup. Allegheny Technologies Inc....
Published:
Last Updated:
ThinkstockWe have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena...
Published:
via Wikimedia CommonsThere is some potentially very good news for those with gastrointestinal stromal tumors. The FDA has granted a priority review to the New Drug Application of Bayer HealthCare and...
Published:
Last Updated:
We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals...
Published:
Last Updated:
The short interest in biotech stocks is mixed, judging by the short interest changes between the September 14 and September 28 settlement dates. There were notable swings in shares sold short from...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Monday. Today’s calls are light perhaps due to the Columbus Day holiday....
Published:
Last Updated:
With a couple of exceptions, the short interest in biotech stocks is on the rise again, judging by the short interest changes from September 14 settlement date versus the August 31 settlement date....
Published:
The NASDAQ OMX Group Inc. (NASDAQ: NDAQ) has announced its changes in the quarterly reranking of the NASDAQ Q-50 Index, and the effects will take place prior to market open on Monday, September 24,...
Published:
Last Updated: